Dr Judy Ann Emanuel, DO | |
111 Bush St, Ashland, OR 97520-2607 | |
(541) 708-0200 | |
(541) 488-7156 |
Full Name | Dr Judy Ann Emanuel |
---|---|
Gender | Female |
Speciality | Physical Medicine & Rehabilitation |
Location | 111 Bush St, Ashland, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467577767 | NPI | - | NPPES |
C77507 | Other | HI | HMSA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | DOS610 (Hawaii) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Judy Ann Emanuel, DO 111 Bush St, Ashland, OR 97520-2607 Ph: (541) 708-0200 | Dr Judy Ann Emanuel, DO 111 Bush St, Ashland, OR 97520-2607 Ph: (541) 708-0200 |
News Archive
Metabolomics is a post-genomic research field for analysis of low molecular weight compounds in biological systems, and its approaches offer an analysis of metabolite level changes in biological samples. Recently, metabolomic method has shown great potentials in identifying the new diagnostic markers and therapeutic targets for cancers. However, metabolomic studies on cancer metastasis remain scarce.
A pair of studies in the July 15 issue of the Journal of the American Medical Association (JAMA) spell out how much closer science has come to unraveling the genetic signature of brain cancer, according to a researcher at the University of Alabama at Birmingham (UAB). Boris Pasche, M.D., Ph.D., director of the UAB Division of Hematology and Oncology, believes these studies represent a new vanguard in the still-changing field of DNA analysis.
Using virtual reality goggles to mix up the sensory signals reaching the brain, scientists have induced out-of-body-like experiences in healthy people, suggesting a scientific explanation for a phenomenon often thought to be a figment of the imagination.
Lowe's has received CEO Cancer Gold Standard accreditation, recognizing the company's commitment to reducing the cancer risk of its employees and their families by encouraging healthy lifestyles and promoting early detection through screenings, and by providing quality care, including access to cancer clinical trials, when a cancer diagnosis becomes a reality.
› Verified 2 days ago